Newborn Screening for Genetic Disorders

NBS Fundamentals - Tiny Patient Protectors

• Primary Goal: Identify infants with specific congenital, genetic, or metabolic disorders before symptom onset.
• Optimal Timing: Blood sample collection between 24-72 hours after birth, or prior to hospital discharge.
• Procedure: Heel-prick capillary blood spotted onto a special filter paper (Guthrie card).
• Impact: Facilitates prompt intervention, mitigating severe health consequences like intellectual disability or death.

⭐ NBS is a crucial public health strategy; conditions screened are typically serious but treatable if caught early.

Screening Criteria & Indian Scene - Who, What, Why India

• Goal: Early detection & intervention to prevent severe outcomes (morbidity, mortality, disability).
• Wilson & Jungner Criteria (Modified): Basis for selecting disorders.
  • Condition: Significant health problem, recognizable early/latent stage, understood natural history.
  • Test: Suitable, acceptable, validated.
  • Treatment: Available, effective.
  • Program: Cost-effective, continuous, agreed policy on who to treat.
• Indian Scenario:
  • NBS largely opportunistic; not yet universal.
  • Commonly screened: Congenital Hypothyroidism (CH), G6PD deficiency, Congenital Adrenal Hyperplasia (CAH).
  • Challenges: Cost, infrastructure, public awareness, follow-up.
  • ICMR guidelines exist; Rashtriya Bal Swasthya Karyakram (RBSK) includes some screening.

  ⭐ Congenital Hypothyroidism is the most common preventable cause of intellectual disability effectively targeted by NBS programs. oka

Testing Toolkit - Dots & Detectives

• Sample: Dried Blood Spots (DBS) on Guthrie card (heel prick).
  • Timing: 24-72 hours post-feed.
• Detection Methods:
  • Tandem Mass Spectrometry (MS/MS): Multiplex analysis from one DBS.
  • Immunoassays (e.g., TSH, 17-OHP).
  • Enzyme assays (e.g., G6PD).
• Confirmation: Specific enzyme/molecular tests if initial screen positive.

⭐ Tandem Mass Spectrometry (MS/MS) is the workhorse, enabling multiplex screening from a single dried blood spot.

Key Disorders Spotlight - Tiny Trouble Spotters

• Congenital Hypothyroidism (CH)
  • Defect: Thyroid dysgenesis/dyshormonogenesis
  • Screen: ↑TSH, ↓T4
  • Clinical: Prolonged jaundice, hoarse cry, macroglossia. Preventable intellectual disability.
• Phenylketonuria (PKU)
  • Defect: Phenylalanine hydroxylase (PAH) deficiency
  • Screen: ↑Phenylalanine (Guthrie test / MS-MS)
  • Clinical: Mousy/musty odor, eczema, intellectual disability.
• Galactosemia (Classical)
  • Defect: Galactose-1-Phosphate Uridyltransferase (GALT) deficiency
  • Screen: ↑Total galactose (or Gal-1-P), ↓GALT activity; Beutler test
  • Clinical: Jaundice, hepatomegaly, cataracts, E. coli sepsis.
• Congenital Adrenal Hyperplasia (CAH)
  • Defect: 21-hydroxylase deficiency (most common)
  • Screen: ↑17-hydroxyprogesterone (17-OHP)
  • Clinical: Ambiguous genitalia (females), salt wasting, virilization.
• G6PD Deficiency
  • Defect: Glucose-6-Phosphate Dehydrogenase deficiency
  • Screen: Fluorescent spot test / enzyme assay
  • Clinical: Neonatal jaundice, acute hemolytic anemia on oxidant stress (e.g., drugs, fava beans).

⭐ Congenital Hypothyroidism is the most common preventable cause of intellectual disability worldwide.

​

Results & Next Steps - Code Red Confirmation

• Positive screen (Code Red) → Immediate recall.
• Confirmatory diagnostic tests (e.g., HPLC, GC/MS, enzyme assay, molecular testing).
• Specialist consultation & management initiation.

⭐ Confirmatory tests are crucial; a positive screen is NOT a diagnosis. False positives occur, necessitating specific diagnostic assays before initiating lifelong treatment or dietary restrictions for conditions like Phenylketonuria (PKU).

High‑Yield Points - ⚡ Biggest Takeaways

• NBS enables early detection and timely intervention for treatable genetic disorders, preventing severe complications.
• Key disorders screened in India: Congenital Hypothyroidism (CH), G6PD deficiency, Congenital Adrenal Hyperplasia (CAH).
• Heel prick blood spot on Guthrie card (24-72 hours post-birth) is the standard sample.
• Tandem Mass Spectrometry (MS/MS) is pivotal for expanded screening of multiple Inborn Errors of Metabolism (IEMs).
• Confirmatory testing is mandatory for any positive screen to avoid misdiagnosis.
• PKU screening often uses Guthrie test or MS/MS; detects phenylalanine hydroxylase deficiency related issues.